Immune Tolerance Network (ITN)

The ITN is a group of basic scientists and clinical investigators who conduct clinical research on immune tolerance therapies for immune-mediated disorders.

Human Immunology Project Consortium (HIPC)

HIPC is a research network that studies the various states of the human immune system by profiling it before and after vaccination, infection, or adjuvant treatment.

Cooperative Centers on Human Immunology (CCHI)

The CCHI program supports multi-disciplinary immunology research to discover new molecules, mechanisms, and pathways governing the human immune system in healthy and vulnerable populations.

AMP AIM Program

The Autoimmune and Immune-Mediated Diseases program within the Accelerating Medicines Partnership® aims to define the interactions that cause inflammation and autoimmune diseases.

Immunology Database and Analysis Portal (ImmPort)

ImmPort is a public data repository that integrates NIAID-funded immunology study data, including basic research and clinical trials, with online tools for analysis and visualization.

TrialShare

TrialShare facilitates clinical trial transparency by providing investigators access to de-identified study data, published analysis methods, and interactive graphical analyses.

Immune Drivers of Autoimmune Disease (IDAD) 

The IDAD program aims to improve our understanding of the immunologic processes underlying the initiation, progression, and clinical course of autoimmune diseases.

Mucosal Immunology Studies Team (MIST) 

The purpose of MIST is to discover and define novel basic immune mechanisms, cells, mediators, and pathways that provide a more sophisticated understanding of mucosal immune defense mechanisms; to explore innovative hypotheses; and to address difficult unsolved questions in mucosal immunity.